Bicycle Therapeutics plc Cash
Bicycle Therapeutics plc (BCYC) had Cash of $438.68 million as of 2021-12-31, per its 10-K filed 2022-03-01.
Discontinued › Balance Sheet › Assets
us-gaap:Cash · last filed 2022-03-01
- 2021-12-31: Cash $438.68M.
- 2021-09-30: Cash $259.52M.
- 2021-06-30: Cash $198.74M.
- 2021-03-31: Cash $195.90M.
| Period end | Cash |
|---|---|
| 2021-12-31 | $438.68M 10-K · filed 2022-03-01 |
| 2021-09-30 | $259.52M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $198.74M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $195.90M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $135.99M 10-K · filed 2022-03-01 |
| 2020-09-30 | $149.84M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $96.91M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $109.64M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $92.12M 10-K · filed 2021-03-11 |
| 2019-09-30 | $95.95M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $108.54M 10-Q · filed 2019-08-08 |
| 2018-12-31 | $63.38M 10-K · filed 2020-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B |